Clinical trial
Study on Risk Factors and Prognostic Value of Non-target Lesion Progression in Patients With Coronary Artery Disease
NCT07748754 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Risk Factors and Prognostic Value of Non-target Lesion Progression in Patients With Coronary Artery Disease
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 1, 2020
- Completion date
- December 31, 2029
- Enrollment
- 1,400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease (cad)